VICTORY CAPITAL MANAGEMENT INC

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 1040188 San Antonio, TX

Position in TSHA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$874,980

-$201,722 QoQ

Shares Held

195,745

-0.0% QoQ

Ownership

0.068%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

VICTORY CAPITAL MANAGEMENT INC holds $2,018,555,898 across 156 Biotechnology names. TSHA ranks #78 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,888,521	$843,300,167
2	RPRX	Royalty Pharma plc	3,853,808	$184,867,169
3	INCY	Incyte Corp	1,742,870	$164,038,924
4	REGN	Regeneron Pharmaceuticals, Inc.	129,074	$99,727,735
5	ALNY	Alnylam Pharmaceuticals, Inc.	195,937	$64,829,675
6	INSM	INSMED Inc	396,245	$64,793,982
7	LGND	Ligand Pharmaceuticals Inc	303,224	$60,538,671
8	JAZZ	Jazz Pharmaceuticals plc	256,598	$48,509,851

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$874,980	195,745	-0.0%	Shares	Sole	2026-05-15
2025-12-31	$1,076,702	195,764	+664.7%	Shares	Sole	2026-02-13
2025-09-30	$83,712	25,600	+0.4%	Shares	Sole	2025-11-12
2025-06-30	$58,886	25,492	+34.0%	Shares	Sole	2025-08-13
2025-03-31	$26,433	19,017	+0.1%	Shares	Sole	2025-05-02
2024-12-31	$32,871	19,001	-5.0%	Shares	Sole	2025-02-06
2024-09-30	$40,214	20,007	+10.8%	Shares	Sole	2024-11-05
2024-06-30	$40,458	18,062	+6.8%	Shares	Sole	2024-08-05
2024-03-31	$48,554	16,918	+8.4%	Shares	Sole	2024-05-03
2023-12-31	$27,612	15,600	—	Shares	Sole	2024-02-05
No filing history on record for this holder in this stock.